Patient presents with [hematuria description, e.g., gross hematuria, microscopic hematuria] and [proteinuria description, e.g., nephrotic-range proteinuria, subnephrotic proteinuria] consistent with a working diagnosis of IgA nephropathy (Berger's disease).  Onset of symptoms occurred [timeframe] and was [acute or insidious].  Associated symptoms include [list symptoms, e.g., flank pain, edema, hypertension, headache, fatigue].  Patient denies [relevant negatives, e.g., dysuria, fever, recent upper respiratory infection].  Relevant medical history includes [list medical history, e.g., hypertension, diabetes, family history of kidney disease].  Physical exam reveals [relevant findings, e.g., normal vital signs, presence of edema, abdominal tenderness].  Laboratory findings show [list lab values, e.g., elevated creatinine, decreased eGFR, abnormal urine protein creatinine ratio, positive IgA deposits on kidney biopsy].  Kidney biopsy, performed on [date], confirmed the diagnosis of IgA glomerulonephritis, demonstrating [biopsy findings, e.g., mesangial IgA deposits, endocapillary proliferation].  Differential diagnosis included other glomerulonephritides such as post-infectious glomerulonephritis, membranoproliferative glomerulonephritis, and thin basement membrane nephropathy.  Based on the clinical presentation, laboratory data, and biopsy results, the diagnosis of IgA nephropathy is established.  The patient was educated on the disease process, prognosis, and treatment options.  Treatment plan includes [list treatment, e.g., blood pressure control with ACE inhibitors or ARBs, corticosteroids, supportive care, referral to nephrology].  Follow-up scheduled in [timeframe] to monitor kidney function, proteinuria, and blood pressure.  ICD-10 code N04.9, IgA nephropathy, is assigned.